Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling

Journal of Virology

Volumn 84, Issue 8, 2010, Pages 3935-3948

  Stolp, Bettina ^a   Abraham, Libin ^a,b   Rudolph, Jochen M ^a   Fackler, Oliver T ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CHEMOKINE; COFILIN; NEF PROTEIN; P21 ACTIVATED KINASE 2; ACTIN DEPOLYMERIZING FACTOR; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 2; NEF PROTEIN, SIV; P21 ACTIVATED KINASE; VIRULENCE FACTOR; VIRUS PROTEIN;

ARTICLE; CELL MOTILITY; COMPLEX FORMATION; CONTROLLED STUDY; DEREGULATION; FLOW CYTOMETRY; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; PRIORITY JOURNAL; PROTEIN INTERACTION; SIMIAN IMMUNODEFICIENCY VIRUS; CELL LINE; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM; PATHOGENICITY; PROTEIN BINDING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; SIMIAN IMMUNODEFICIENCY VIRUS;

ACTIN DEPOLYMERIZING FACTORS; ACTINS; CELL LINE; HIV-1; HIV-2; HUMANS; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; P21-ACTIVATED KINASES; PROTEIN BINDING; SIMIAN IMMUNODEFICIENCY VIRUS; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRULENCE FACTORS;

EID: 77950514618     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02467-09     Document Type: Article

References (45)

1. Agopian, K., B. L. Wei, J. V. Garcia, and D. Gabuzda. 2006. A hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2. J. Virol. 80: 3050-3061.
2. Arora, V. K., R. P. Molina, J. L. Foster, J. L. Blakemore, J. Chernoff, B. L. Fredericksen, and J. V. Garcia. 2000. Lentivirus Nef specifically activates Pak2. J. Virol. 74: 11081-11087.
3. Bamburg, J. R., and B. W. Bernstein. 2008. ADF/cofilin. Curr. Biol. 18: R273-R275.
4. Bokoch, G. M. 2003. Biology of the p21-activated kinases. Annu. Rev. Biochem. 72: 743-781.
5. Brown, A., X. Wang, E. Sawai, and C. Cheng-Mayer. 1999. Activation of the PAK-related kinase by human immunodeficiency virus type 1 Nef in primary human peripheral blood lymphocytes and macrophages leads to phosphorylation of a PIX-p95 complex. J. Virol. 73: 9899-9907.
6. Carl, S., A. J. Iafrate, S. M. Lang, N. Stolte, C. Stahl-Hennig, K. Matz- Rensing, D. Fuchs, J. Skowronski, and F. Kirchhoff. 2000. Simian immunodeficiency virus containing mutations in N-terminal tyrosine residues and in the PxxP motif in Nef replicates efficiently in rhesus macaques. J. Virol. 74: 4155-4164.
7. Deacon, N. J., A. Tsykin, A. Solomon, K. Smith, M. Ludford-Menting, D. J. Hooker, D. A. McPhee, A. L. Greenway, A. Ellett, C. Chatfield, et al. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270: 988-991.
8. Fackler, O. T., and A. S. Baur. 2002. Live and let die: Nef functions beyond HIV replication. Immunity 16: 493-497.
9. Fackler, O. T., A. Moris, N. Tibroni, S. I. Giese, B. Glass, O. Schwartz, and H. G. Kräusslich. 2006. Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology 351: 322-339.
10. Fackler, O. T., X. Lu, J. A. Frost, M. Geyer, B. Jiang, W. Luo, A. Abo, A. S. Alberts, and B. M. Peterlin. 2000. p21-activated kinase 1 plays a critical role in cellular activation by Nef. Mol. Cell. Biol. 20: 2619-2627.
11. Geyer, M., O. T. Fackler, and B. H. Peterlin. 2001. Structure-function relationships in HIV-1 Nef. EMBO Rep. 2: 580-585.
12. Haller, C., S. Rauch, N. Michel, S. Hannemann, M. J. Lehmann, O. T. Keppler, and O. T. Fackler. 2006. The HIV-1 pathogenicity factor Nef interferes with maturation of stimulatory T-lymphocyte contacts by modulation of N-Wasp activity. J. Biol. Chem. 281: 19618-19630.
13. Hanna, Z., D. G. Kay, N. Rebai, A. Guimond, S. Jothy, and P. Jolicoeur. 1998. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell 95: 163-175.
14. Kestler, H. W., III, D. J. Ringler, K. Mori, D. L. Panicali, P. K. Sehgal, M. D. Daniel, and R. C. Desrosiers. 1991. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65: 651-662.
15. Khan, I., E. Sawai, E. Antonio, C. Weber, C. Mandell, P. Montbriand, and P. Luciw. 1998. Role of the SH3-ligand domain of simian immunodeficiency virus Nef in interaction with Nef-associated kinase and simian AIDS in rhesus macaques. J. Virol. 72: 5820-5830.
16. Kirchhoff, F., T. C. Greenough, D. B. Brettler, J. L. Sullivan, and R. C. Desrosiers. 1995. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N. Engl. J. Med. 332: 228-232.
17. Kirchhoff, F., M. Schindler, N. Bailer, G. Renkema, K. Saksela, V. Knoop, M. Müller-Trutwin, M. Santiago, F. Bibollet-Ruche, M. Dittmar, J. Heeney, B. Hahn, and J. Münch. 2004. Nef proteins from simian immunodeficiency virus-infected chimpanzees interact with p21-activated kinase 2 and modulate cell surface expression of various human receptors. J. Virol. 78: 6864-6874.
18. Krautkrämer, E., S. I. Giese, J. Gasteier, W. Muranyi, and O. T. Fackler. 2004. Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts. J. Virol. 78: 4085-4097.
19. Lang, S., A. Iafrate, C. Stahl-Hennig, E. Kuhn, T. Nisslein, F. Kaup, M. Haupt, G. Hunsmann, J. Skowronski, and F. Kirchhoff. 1997. Association of simian immunodeficiency virus Nef with cellular serine/threonine kinases is dispensable for the development of AIDS in rhesus macaques. Nat. Med. 3: 860-865.
20. Lu, X., X. Wu, A. Plemenitas, H. Yu, E. Sawai, A. Abo, and B. H. Peterlin. 1996. CDC42 and Rac1 are implicated in the activation of the Nef-associated kinase and replication of HIV-1. Curr. Biol. 6: 1677-1684.
21. Luo, T., and J. V. Garcia. 1996. The association of Nef with a cellular serine/threonine kinase and its enhancement of infectivity are viral isolate dependent. J. Virol. 70: 6493-6496.
22. Malim, M., and M. Emerman. 2008. HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 3: 388-398.
23. Michel, N., I. Allespach, S. Venzke, O. T. Fackler, and O. T. Keppler. 2005. The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr. Biol. 15: 714-723.
24. Michel, N., K. Ganter, S. Venzke, J. Bitzegeio, O. T. Fackler, and O. T. Keppler. 2006. The Nef protein of human immunodeficiency virus is a broadspectrum modulator of chemokine receptor cell surface levels that acts independently of classical motifs for receptor endocytosis and Galphai signaling. Mol. Biol. Cell 17: 3578-3590.
25. Moir, S., and A. Fauci. 2009. B cells in HIV infection and disease. Nat. Rev. Immunol. 9: 235-245.
26. Nobile, C., D. Rudnicka, M. Hasan, N. Aulner, F. Porrot, C. Machu, O. Renaud, M. Prévost, C. Hivroz, O. Schwartz, and N. Sol-Foulon. 2010. HIV-1 Nef inhibits ruffles, induces filopodia, and modulates migration of infected lymphocytes. J. Virol. 84: 2282-2293.
27. Nunn, M. F., and J. W. Marsh. 1996. Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family. J. Virol. 70: 6157-6161.
28. O'Neill, E., L. Kuo, J. Krisko, D. Tomchick, J. Garcia, and J. Foster. 2006. Dynamic evolution of the human immunodeficiency virus type 1 pathogenic factor, Nef. J. Virol. 80: 1311-1320.
29. Ott, T., A. Pahuja, S. Nickolls, D. Alleva, and R. Struthers. 2004. Identification of CC chemokine receptor 7 residues important for receptor activation. J. Biol. Chem. 279: 42383-42392.
30. Pulkkinen, K., G. H. Renkema, F. Kirchhoff, and K. Saksela. 2004. Nef associates with p21-activated kinase 2 in a p21-GTPase-dependent dynamic activation complex within lipid rafts. J. Virol. 78: 12773-12780.
31. Rauch, S., K. Pulkkinen, K. Saksela, and O. T. Fackler. 2008. Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity. J. Virol. 82: 2918-2929.
32. Renkema, G. H., A. Manninen, and K. Saksela. 2001. Human immunodeficiency virus type 1 Nef selectively associates with a catalytically active subpopulation of p21-activated kinase 2 (PAK2) independently of PAK2 binding to Nck or beta-PIX. J. Virol. 75: 2154-2160.
33. Renkema, G. H., A. Manninen, D. A. Mann, M. Harris, and K. Saksela. 1999. Identification of the Nef-associated kinase as p21-activated kinase 2. Curr. Biol. 9: 1407-1410.
34. Roeth, J., and K. Collins. 2006. Human immunodeficiency virus type 1 Nef: adapting to intracellular trafficking pathways. Microbiol. Mol. Biol. Rev. 70: 548-563.
35. Rudolph, J. M., N. Eickel, C. Haller, M. Schindler, and O. T. Fackler. 2009. Inhibition of T-cell receptor-induced actin remodeling and relocalization of Lck are evolutionarily conserved activities of lentiviral Nef proteins. J. Virol. 83: 11528-11539.
36. Sawai, E. T., I. Khan, P. Montbriand, B. H. Peterlin, C. Cheng-Mayer, and P. Luciw. 1996. Activation of PAK by HIV and SIV Nef: importance for AIDS in rhesus macaques. Curr. Biol. 6: 1519-1527.
37. Sawai, E. T., A. Baur, H. Struble, B. M. Peterlin, J. A. Levy, and C. Cheng- Mayer. 1994. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 91: 1539-1543.
38. Schindler, M., J. Münch, O. Kutsch, H. Li, M. Santiago, F. Bibollet-Ruche, M. Müller-Trutwin, F. Novembre, M. Peeters, V. Courgnaud, E. Bailes, P. Roques, D. Sodora, G. Silvestri, P. Sharp, B. Hahn, and F. Kirchhoff. 2006. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125: 1055-1067.
39. Schindler, M., D. Rajan, A. Specht, C. Ritter, K. Pulkkinen, K. Saksela, and F. Kirchhoff. 2007. Association of Nef with p21-activated kinase 2 is dispensable for efficient human immunodeficiency virus type 1 replication and cytopathicity in ex vivo-infected human lymphoid tissue. J. Virol. 81: 13005-13014.
40. Stolp, B., M. Reichman-Fried, L. Abraham, X. Pan, S. I. Giese, S. Hannemann, P. Goulimari, E. Raz, R. Grosse, and O. T. Fackler. 2009. HIV-1 Nef interferes with host cell motility by deregulation of Cofilin. Cell Host Microbe 6: 174-186.
41. Sugimoto, C., K. Tadakuma, I. Otani, T. Moritoyo, H. Akari, F. Ono, Y. Yoshikawa, T. Sata, S. Izumo, and K. Mori. 2003. nef gene is required for robust productive infection by simian immunodeficiency virus of T-cell-rich paracortex in lymph nodes. J. Virol. 77: 4169-4180.
42. Tolstrup, M., L. Ostergaard, A. Laursen, S. Pedersen, and M. Duch. 2004. HIV/SIV escape from immune surveillance: focus on Nef. Curr. HIV Res. 2: 141-151.
43. Vincent, P., E. Priceputu, D. Kay, K. Saksela, P. Jolicoeur, and Z. Hanna. 2006. Activation of p21-activated kinase 2 and its association with Nef are conserved in murine cells but are not sufficient to induce an AIDS-like disease in CD4C/HIV transgenic mice. J. Biol. Chem. 281: 6940-6954.
44. Wolf, D., V. Witte, B. Laffert, K. Blume, E. Stromer, S. Trapp, P. d'Aloja, A. Schürmann, and A. S. Baur. 2001. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat. Med. 7: 1217-1224.
45. Xu, W., P. Santini, J. Sullivan, B. He, M. Shan, S. Ball, W. Dyer, T. Ketas, A. Chadburn, L. Cohen-Gould, D. Knowles, A. Chiu, R. Sanders, K. Chen, and A. Cerutti. 2009. HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat. Immunol. 10: 1008-1017.